Last reviewed · How we verify

NCT05689294

Non Invasive Continuous Blood Pressure Sensor

Completed Last updated 18 November 2023
What this trial tests

trial in Blood Pressure in 15 participants. Completed in 30 October 2023.

Timeline
1 April 2023
Primary endpoint
30 October 2023
30 October 2023

Quick facts

Lead sponsorDartmouth-Hitchcock Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date1 April 2023
Primary completion30 October 2023
Estimated completion30 October 2023
Sites1 location across United States

Conditions studied

Sponsor

Dartmouth-Hitchcock Medical Center

Who can join

Adults 18 to 100, any sex, with Blood Pressure or Arterial Line. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to collect training data in order to establish a method for correlating arterial blood pressure with voltage output signals from a non-invasive piezoelectric array sensor placed on the skin superficial to the radial artery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

Other Dartmouth-Hitchcock Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05689294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing